Drug Regulatory Affairs

Problem

Drug regulatory requirements are scattered across NMPA/CDE, FDA, EMA, and ICH frameworks. Practitioners often struggle to know which rule applies, what legal or guideline level it sits at, and whether China, US, or EU treatment differs. This skill focuses on registration, clinical, CMC, and GMP compliance questions, turning a simple rule lookup into a clearer answer with applicable market, regulatory basis, practical impact, and official sources.

How It Works

• Scope first: It maps keywords to target markets (NMPA/CDE, FDA, EMA, ICH), regulatory areas (registration pathways, IND/NDA/BLA, CMC, GMP, post-marketing), and depth (quick lookup, detailed interpretation, cross-market comparison).
• Search in parallel: It prioritizes official sources such as gov.cn, fda.gov, ema.europa.eu, and ich.org, then supplements with professional pharma regulatory platforms and user knowledge bases.
• Structured output: It applies templates for single-regulation lookups, cross-market comparison, detailed interpretation, and GMP briefings, keeping comparison dimensions consistent and key points traceable.
• Source tracing: It annotates important conclusions with regulation numbers, guideline titles, or official links to reduce reliance on second-hand summaries.

Boundaries

This skill is useful for regulatory framework mapping, early cross-market difference checks, and preparation before internal discussion. It still should not replace CRO, legal, or regulatory owners, especially for eCTD modules, marketing authorization changes, pharmacovigilance, review timelines, and specific CMC requirements, where the latest official texts remain authoritative.